Herein we investigate the difference between Kawasaki disease (KD) with and without a recent history of SARS-CoV-2 infection.
We compared the clinical characteristics of patients with KD during the SARS-CoV-2 pandemic in a single children's hospital in Korea. Fifty-two patients were enrolled and divided into group 1 (with a history of COVID-19, 
The median age of patients was significantly higher in group 1 than in group 2 (53 months [IQR, 24-81] vs. 15 months [IQR, 6-33], 
Post-COVID KD showed a stronger inflammatory response than KD-alone, with no differences in cardiac complications.